BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12110035)

  • 1. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
    Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
    Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.
    Erixon M; Lindén T; Kjellstrand P; Carlsson O; Ernebrant M; Forsbäck G; Wieslander A; Jönsson JA
    Perit Dial Int; 2004; 24(4):392-8. PubMed ID: 15335155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
    Perit Dial Int; 2005; 25(6):583-90. PubMed ID: 16411526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
    Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
    Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature: the single most important factor for degradation of glucose fluids during storage.
    Kjellstrand P; Erixon M; Wieslander A; Lindén T; Martinson E
    Perit Dial Int; 2004; 24(4):385-91. PubMed ID: 15335154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S28-31. PubMed ID: 19270226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-DGE in peritoneal dialysis fluids cannot be found in plasma after infusion into the peritoneal cavity.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Jönsson JA; Simonsen O; Kjellstrand P
    Perit Dial Int; 2008; 28(3):277-82. PubMed ID: 18474921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to avoid glucose degradation products in peritoneal dialysis fluids.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
    Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids.
    Yamamoto T; Tomo T; Okabe E; Namoto S; Suzuki K; Hirao Y
    Nephrol Dial Transplant; 2009 May; 24(5):1436-42. PubMed ID: 19033251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes.
    Ortiz A; Wieslander A; Linden T; Santamaria B; Sanz A; Justo P; Sanchez-Niño MD; Benito A; Kjellstrand P
    Curr Med Chem; 2006; 13(22):2695-702. PubMed ID: 17017920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?
    Zeier M; Schwenger V; Deppisch R; Haug U; Weigel K; Bahner U; Wanner C; Schneider H; Henle T; Ritz E
    Kidney Int; 2003 Jan; 63(1):298-305. PubMed ID: 12472796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
    Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
    Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro?
    Wieslander AP; Andrén AH; Nilsson-Thorell C; Muscalu N; Kjellstrand PT; Rippe B
    Perit Dial Int; 1995; 15(8):348-52. PubMed ID: 8785233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.
    Mittelmaier S; Niwa T; Pischetsrieder M
    J Ren Nutr; 2012 Jan; 22(1):181-5. PubMed ID: 22200439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.
    Wieslander AP; Nordin MK; Kjellstrand PT; Boberg UC
    Kidney Int; 1991 Jul; 40(1):77-9. PubMed ID: 1921158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation in peritoneal dialysis fluids may be avoided by using low pH and high glucose concentration.
    Kjellstrand P; Martinson E; Wieslander A; Kjellstrand K; Jeppsson E; Svensson E; Järkelid L; Linden T; Olsson LF
    Perit Dial Int; 2001; 21(4):338-44. PubMed ID: 11587395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS.
    Mittelmaier S; Fünfrocken M; Fenn D; Fichert T; Pischetsrieder M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):877-82. PubMed ID: 20189892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation.
    Mittelmaier S; Fünfrocken M; Fenn D; Pischetsrieder M
    Anal Bioanal Chem; 2011 Feb; 399(4):1689-97. PubMed ID: 21136045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose degradation products in peritoneal dialysis fluids: how they can be avoided.
    Wieslander A; Linden T; Kjellstrand P
    Perit Dial Int; 2001; 21 Suppl 3():S119-24. PubMed ID: 11887805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.
    Tomo T; Okabe E; Yamamoto T; Namoto S; Iwashita T; Matsuyama K; Kadota J
    J Artif Organs; 2007; 10(1):47-51. PubMed ID: 17380297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.